MedTrace Logo

Management of RPOC After Induced Abortion

NCT04685694 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2022-05-03

No results posted yet for this study

Summary

Randomized trial comparing expectant management and medical management in women diagnosed with retained products of conception after first trimester induced abortion

Conditions

  • Abortion Induced Complicated

Interventions

DRUG

Misoprostol

sl 800 mcg misoprostol

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Yossi Tzur, MD · Tel Aviv Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2022-01-31
FDA Drug
Yes

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04685694 on ClinicalTrials.gov